Trial to Assess the Safety and Efficacy of Sirolimus-Coated Balloon vs. Uncoated Standard Angioplasty for the Treatment of Below-the-knee Peripheral Arterial Disease
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 230 participants.
Also called NCT04772300
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 230 participants
- Registry
-
NCT04772300
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Austria, Germany
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04772300. Randomized; double masking; primary purpose treatment. Start 2022-02-10 (actual); primary completion 2026-04-17 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Trial to Assess the Safety and Efficacy of Sirolimus-Coated Balloon vs. Uncoated Standard Angioplasty for the Treatment of Below-the-knee Peripheral Arterial Disease
- Acronym
- LIMES
- Condition
- Peripheral Artery Disease
- Intervention (Combination product)
- Percutaneous Transluminal Angioplasty (PTA) MagicTouch Sirolimus Coated PTA Balloon Catheter
- Intervention (Device)
- Percutaneous Transluminal Angioplasty (PTA) with non-coated balloon catheter (POBA)
- Lead sponsor
- Jena University Hospital
- Collaborator
- Concept Medical Inc.
- Collaborator
- Vascuscience
- Collaborator
- CoreLab Black Forest
- Collaborator
- Center for Clinical Studies Jena
Record details
- Record id
cardio:ct-nct04772300- Content hash
406273f3eaed25ea4c6f092ef56e9ff92156eda03af3dae660dfb0a8e537ca15